Home » Newsletters » BioWorld

BioWorld

June 9, 1995

View Archived Issues

LATE 1996 FINISH ON FDA REFORM LEGISLATION PREDICTED

COCENSYS COMPLETES $12.1M SELF-MANAGED PRIVATE PLACEMENT

RIBOZYME, PARKE-DAVIS EXTEND OSTEOARTHRITIS COLLABORATION

CHEMEX GETS MONEY TO SURVIVE FROM SALE OF AMLEXANOX

RESEARCHERS DISCOVER BRAIN'S SLEEP-PROVOKING MOLECULE

ORAVAX RAISES $23M IN 1995'S THIRD INITIAL PUBLIC OFFERING

PROGENITOR COLLABORATES WITH NOVO NORDISK SUBSIDIARY, INKS SECOND $50M

NEXSTAR'S DAUNOXOME WINS APPROVAL FROM FDA ADVISORY PANEL